Back

Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry

27 August 2022 (12:15 - 13:00)
Organised by:
Congress Presentation Part of: Epidemiological aspects of atrial fibrillation Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Wern Yew Ding

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Changes in incidences of clinical outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study since 2010.
Professor L. Fauchier (Tours, FR)
Abstract Slides
Presentation thumbnail
Micronutrient deficiencies and new-onset atrial fibrillation in a community-based cohort: Data from PREVEND
Mr A. Al Mubarak (Groningen, NL)
Abstract Slides
Presentation thumbnail
Bone morphogenetic protein 10 as predictor for adverse outcomes in patients with atrial fibrillation
Doctor E. Hennings (Basel, CH)
Abstract Slides
Presentation thumbnail
Impact of the atrial fibrillation better care pathway in clinically complex patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF General Long-Term Registry
Doctor G. Romiti (Rome, IT)
Abstract Slides
Presentation thumbnail
Prediction of incident atrial fibrillation with GDF-15 and echocardiographic left atrial volumes: data from the Akershus cardiac examination 1950 study
Doctor P. Roenningen (Baerum, NO)
Abstract Slides

Access the full session

Session thumbnail
Epidemiological aspects of atrial fibrillation

The Event

Event poster

ESC Congress 2022

27 August 2022 12:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources